RUSSO RENE (CEO and President) purchased 14.8% of their position (36.29K shares) of XILIO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $24.7K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/18/2025ACC: 0001415889-25-017704
DirectorOfficer10% Owner· CEO and President
Since Oct 2021
+36.29K
Net shares
Net buyer
$24.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
36.29K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+36.29K
Price / share
$0.68
Trade value
$24.68K
% of position
14.8%
6/16/2025
244.88K→281.17K
Total
Net shares
+36.29K
Net value
$24.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2025 | P · Purchase | +36.29K | $0.68 | $24.68K | 14.8% | 244.88K | 281.17K |
| Total | +36.29K | $24.68K | ||||||
Derivative Transactions0
No derivative transactions reported